[Development of plasma levels of decarboxyprothrombin and vitamin K during treatment with moxalactam].
Lefrère
J J
JJ
Leclercq
M
M
Guillaumont
M
M
Gozin
D
D
Lerable
J
J
D015415:Biomarkers; D006801:Humans; D008297:Male; D008875:Middle Aged; D009070:Moxalactam / Q000009:adverse effects*; D011498:Protein Precursors; D011516:Prothrombin / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D018805:Sepsis / Q000097:blood; D014812:Vitamin K / Q000097:blood*
D015415:Biomarkers; D011498:Protein Precursors; D014812:Vitamin K; C008208:acarboxyprothrombin; D011516:Prothrombin; D009070:Moxalactam
Evolution des taux plasmatiques de décarboxyprothrombine et de vitamine K au cours du traitement par Moxalactam.